The global classical swine fever vaccine market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). In swine herds, vaccination is a critical tool for disease control and prevention. The market is anticipated to witness substantial growth majorly owing to the contributions of government as well as non-government organizations towards research studies. This vaccine supports the prevention of contagious swine fever among pigs, through passive and active immunity as a method of disease protection. Porcine echovirus (PTV) is a non-enveloped RNA virus belonging to the genus Teschovirus and the family Picornaviridae, according to the Swine Health Information Center (SWIC). Thus, to prevent the swineherds from these contagious diseases, their vaccine market is anticipated to grow during the forecast period.

Furthermore, technological advancements in the field of medicine, such as genetically engineered vaccines, are contributing to market growth. Moreover, the surge in the demand for the vaccine is another factor imposing a positive outlook on the market. Different regulations and policies of different countries govern the approval and authorization of animal vaccinations. For instance, the Center for Veterinary Biologics (CVB) of the USDA’s Animal and Plant Health Inspection Service (APHIS) regulates vaccine production and marketing in the US.

Some key players operating in the market include Merck & Co., Inc., and Ceva Santé Animale, among others. These players are eyeing strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launches, development in the existing product portfolio, increasing R&D for effective vaccines, and so on. For instance, in May 2020, Indian Immunological announced the launch of the classical swine fever (CSF) vaccine under the brand name ‘Raksha Class’.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Merck & Co., Inc., and Ceva Santé Animale, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Classical Swine Fever Vaccine Market by Segmentation

By Type 

• Tissue Culture Origin

• Cell Line Origin

By Distribution

• Government Tender

• Market Sales 

Global Classical Swine Fever Vaccine Market by Region